Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Life360 Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Life360 Inc. May 29, 202488.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 26, 2026 | Life360 Inc. | Open-market sale | −27,466 | $44.31 | $1,217,018 |
| Aug 25, 2026 | Life360 Inc. | Open-market sale | −5,833 | $45.05 | $262,777 |
| Aug 19, 2026 | Life360 Inc. | Option exercise | +12,203 | $13.35 | $162,910 |
| Aug 19, 2026 | Life360 Inc. | Option exercise | +21,769 | $8.19 | $178,288 |
| May 29, 2026 | Life360 Inc. | Grant or award | +4,600 | — | — |
| Mar 17, 2026 | Life360 Inc. | Gift | −8,333 | — | — |
| Dec 16, 2025 | Life360 Inc. | Open-market sale | −2,448 | $63.63 | $155,766 |
| Dec 16, 2025 | Life360 Inc. | Open-market sale | −1,518 | $64.49 | $97,896 |
| Aug 18, 2025 | Life360 Inc. | Open-market sale | −25,000 | $85.80 | $2,145,000 |
| Aug 15, 2025 | Life360 Inc. | Open-market sale | −24,919 | $84.23 | $2,098,927 |
| Aug 15, 2025 | Life360 Inc. | Open-market sale | −81 | $85.25 | $6,905 |
| May 29, 2025 | Life360 Inc. | Grant or award | +2,810 | — | — |
| Mar 10, 2025 | Life360 Inc. | Open-market sale | −24,847 | $43.43 | $1,079,105 |
| Mar 10, 2025 | Life360 Inc. | Open-market sale | −153 | $44.04 | $6,738 |
| Nov 26, 2024 | Life360 Inc. | Open-market sale | −10,723 | $43.81 | $469,775 |
Questions about James Synge
What boards is James Synge on?
James Synge sits on the board of Life360 Inc.
How long has James Synge served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.